Pureland Global Venture

Pureland Global Venture (“Pureland”) is a global healthcare venture capital firm. As Enterprise Singapore’s designated co-investment partner, our mission is to deliver medical solutions and savings to over 100 million people around the world. At Pureland, we look for visionary entrepreneurs who combine integrity, intelligence, and passion to address pressing healthcare challenges innovatively and ethically. Focused on early to growth-stage investments, Pureland specializes in sectors including medical devices, digital health, healthcare services, and AI-empowered solutions. We have particular interests in areas such as oncology, ophthalmology, brain health, orthopedics, cardiology, and other chronic disease management. Our globally diversified portfolio comprises 60% allocation in the U.S. and the remaining 40% distributed across Singapore, India, and the EU. Our engagement extends beyond financial investment. We provide robust post-investment support, focusing on strategy development, distribution, cross-border expansion, and manufacturing/OEM partnerships. We strive to establish an ecosystem that fosters collaboration among start-ups, government bodies, clinical, investment, and commercial partners. This approach ensures that portfolio companies receive comprehensive support, aiding in their growth and impactful contribution to the healthcare sector.